Prediction of hematopoietic stem cell yield after mobilization with granulocyte–colony‐stimulating factor in healthy unrelated donors

By  

TRANSFUSION, Vol. 55, Iss. 12, 2015-12 ,pp. : 2855-2863

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biosimilar granulocyte–colony‐stimulating factor for healthy donor stem cell mobilization: need we be afraid?

By  

TRANSFUSION, Vol. 55, Iss. 2, 2015-02 ,pp. : 430-439

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of early short-term cardiac rehabilitation after acute ST-elevation and non-ST-elevation myocardial infarction on 1-year mortality

By Jünger Claus   Rauch Bernhard   Schneider Steffen   Liebhart Nadine   Rauch Geraldine   Senges Jochen   Bestehorn Kurt  

Current Medical Research and Opinion, Vol. 26, Iss. 4, 2010-04 ,pp. : 803-811

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of Dutch guideline for just‐in‐time addition of plerixafor to stem cell mobilization in patients who fail with granulocyte–colony‐stimulating factor

By  

TRANSFUSION, Vol. 55, Iss. 5, 2015-05 ,pp. : 1021-1027

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intermediate doses of cytarabine plus granulocyte–colony‐stimulating factor as an effective and safe regimen for hematopoietic stem cell collection in lymphoma patients with prior mobilization failure

By  

TRANSFUSION, Vol. 55, Iss. 4, 2015-04 ,pp. : 875-879

John Wiley & Sons Inc

Access to resources Recommend Favorite